What is the address of Eurodrug Laboratories?

The registered office of Eurodrug Laboratories is located at Kortrijksesteenweg 214 box 2, 9830 Sint-Martens-Latem.

Is Eurodrug Laboratories still active?

Yes. According to the CBE (29 October 2026) Eurodrug Laboratories is active, legal situation “Normale toestand”, started on 19 February 1985.

Is Eurodrug Laboratories registered on Peppol?

No, Eurodrug Laboratories is currently not registered on the Peppol network.

What is the enterprise number of Eurodrug Laboratories?

The enterprise number of Eurodrug Laboratories is BE0427927178.

When was Eurodrug Laboratories founded?

Eurodrug Laboratories was founded on 19 February 1985.

Who are the directors of Eurodrug Laboratories?

According to the 2025 annual accounts, the directors of Eurodrug Laboratories are: Broesma Eelco Michael, De Libero Emanuele.

Is Eurodrug Laboratories a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 19 February 1985; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Eurodrug Laboratories make in 2025?

Eurodrug Laboratories posted a profit after taxes of € 393 in financial year 2025.

What is the revenue of Eurodrug Laboratories?

As a small company, Eurodrug Laboratories is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -157.

Eurodrug Laboratories (Public Limited)

Dossier Eurodrug Laboratories, printed on 29 October 2026 from databakkes.be/en/0427927178/eurodrug-laboratories. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

Eurodrug Laboratories from Sint-Martens-Latem, company number BE0427927178, closed financial year 2025 with a result of € 393 after tax. For that financial year Eurodrug Laboratories recorded a gross margin of € -157 and equity of € 169,193. Compared with financial year 2024, the result moved from € 11,056 to € 393. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on October 15, 2026.

What it is worth Growing

€ 169,193

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 393

▼ 96% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 11,273

▼ 70% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 107,693.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 848,311

▲ 36% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -13,221 Gross margin 2022: € -13,221 First fiscal year in the series	€ 2,501 Gross margin 2023: € 2,501 ▲ € 15,722 vs 2022 (€ -13,221) Favourable step	€ 12,601 Gross margin 2024: € 12,601 ▲ € 10,100 vs 2023 (€ 2,501) Favourable step	€ -157 Gross margin 2025: € -157 ▼ € 12,758 vs 2024 (€ 12,601) Unfavourable step	▼ € 12,758
Profit after taxes	€ -17,204 Profit after taxes 2022: € -17,204 First fiscal year in the series	€ -2,518 Profit after taxes 2023: € -2,518 ▲ € 14,686 vs 2022 (€ -17,204) Favourable step	€ 11,056 Profit after taxes 2024: € 11,056 ▲ € 13,574 vs 2023 (€ -2,518) Favourable step	€ 393 Profit after taxes 2025: € 393 ▼ 96% vs 2024 (€ 11,056) Unfavourable step	▼ 96%
Equity	€ 160,261 Equity 2022: € 160,261 First fiscal year in the series	€ 157,744 Equity 2023: € 157,744 ▼ 2% vs 2022 (€ 160,261) Unfavourable step	€ 168,800 Equity 2024: € 168,800 ▲ 7% vs 2023 (€ 157,744) Favourable step	€ 169,193 Equity 2025: € 169,193 Unchanged (€ 168,800) Favourable step
Total debts	€ 771,450 Total debts 2022: € 771,450 First fiscal year in the series	€ 1,083,446 Total debts 2023: € 1,083,446 ▲ 40% vs 2022 (€ 771,450) Unfavourable step	€ 1,562,417 Total debts 2024: € 1,562,417 ▲ 44% vs 2023 (€ 1,083,446) Unfavourable step	€ 1,858,273 Total debts 2025: € 1,858,273 ▲ 19% vs 2024 (€ 1,562,417) Unfavourable step	▲ 19%
Cash	€ 80,228 Cash 2022: € 80,228 First fiscal year in the series	€ 21,363 Cash 2023: € 21,363 ▼ 73% vs 2022 (€ 80,228) Unfavourable step	€ 38,147 Cash 2024: € 38,147 ▲ 79% vs 2023 (€ 21,363) Favourable step	€ 11,273 Cash 2025: € 11,273 ▼ 70% vs 2024 (€ 38,147) Unfavourable step	▼ 70%
Retained profit	€ 98,761 Retained profit 2022: € 98,761 First fiscal year in the series	€ 96,244 Retained profit 2023: € 96,244 ▼ 3% vs 2022 (€ 98,761) Unfavourable step	€ 107,300 Retained profit 2024: € 107,300 ▲ 11% vs 2023 (€ 96,244) Favourable step	€ 107,693 Retained profit 2025: € 107,693 Unchanged (€ 107,300) Favourable step
Balance sheet total	€ 931,711 Balance sheet total 2022: € 931,711 First fiscal year in the series	€ 1,241,190 Balance sheet total 2023: € 1,241,190 ▲ 33% vs 2022 (€ 931,711) Unchanged	€ 1,731,216 Balance sheet total 2024: € 1,731,216 ▲ 39% vs 2023 (€ 1,241,190) Unchanged	€ 2,027,466 Balance sheet total 2025: € 2,027,466 ▲ 17% vs 2024 (€ 1,731,216) Unchanged	▲ 17%

Key figures of Eurodrug Laboratories, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Eurodrug Laboratories?

What happened at Eurodrug Laboratories in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 15, 2026 New annual accounts for financial year 2025: profit of € 393 (▼ 96% vs 2024). filed late Source: NBB ↗
2025 De Libero Emanuele became a director. NBB
Feb 19, 1985 New establishment in Sint-Martens-Latem. KBO
Feb 19, 1985 Start of the company according to the CBE. KBO

In short

From € 17,204 loss in 2022 to € 393 profit in 2025.

Paid € 2,177 in corporate taxes since 2022.

Best year ever: 2024, with € 11,056 profit.

Original PDFs at the National Bank ↗

Management

Broesma Eelco Michael De Libero Emanuele

Eurodrug Laboratories

Behind Eurodrug Laboratories are Broesma Eelco Michael and De Libero Emanuele.

Directors

According to the 2025 annual accounts

Broesma Eelco Michael

Director

De Libero Emanuele

Director

since 2025

Establishments

Establishment units

Physical locations of this company

Registered office

Kortrijksesteenweg 214 box 2

9830 Sint-Martens-Latem

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

Drie Sleutels Vierschaar

TriNetX Europe

€ 2.2 million gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0427.927.178
VAT number: BE 0427.927.178
Registered office: Kortrijksesteenweg 214 bus 2, 9830 Sint-Martens-Latem
Names & denominations: Eurodrug Laboratories
Enterprise type: Rechtspersoon
Legal form: Public limited company
Legal situation: Normale toestand
Start date: 19 February 1985
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗